1. AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients. (23rd January 2014) Authors: Pascal, V.; Sundström, Y.; Fasth, A.; Malmström, V.; Berg, L.; Kvist, P.H.; Spee, P.; Galsgaard, E.D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1165: BETALUTIN® IN PATIENTS WITH RELAPSED/ REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT. (23rd June 2022) Authors: Illidge, T.; Beasley, M.; Codina, J. G.; Cavallo, F.; Pascal, V.; Wills, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0110 Affinity and potency of the anti-NKG2A MAB NNC141-0100: Implications for mabel and dosing in the first-in-man trial in rheumatoid arthritis. (23rd January 2014) Authors: Alifrangis, L.; André, P.; Pascal, V.; Bonnet, E.; Radzikowski, L.; Petersen, M.B.; Bléry, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗